Condition
Polypharmacy Patients
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Active Not Recruiting1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06110156Not ApplicableActive Not Recruiting
Population Health Approach to Optimizing Medications in Older Adults
NCT06766071Recruiting
IPGx PILOT Whole Genome Sequencing Extension Cohort
NCT05589870CompletedPrimary
Assessment of a Novel Algorithm System for Polypharmacy Patient Medication Safety and Consultation
NCT04945447Not ApplicableUnknownPrimary
Improving Medication Reviews to Polypharmacy Patients
Showing all 4 trials